Currently out of the existing stock ratings of Boris Peaker, 23 are a HOLD (38.98%), 36 are a BUY (61.02%).

Boris Peaker

Work Performance Price Targets & Ratings Chart

Analyst Boris Peaker, currently employed at TD COWEN, carries an average stock price target met ratio of 66.71% that have a potential upside of 34.14% achieved within 126 days. Previously, Boris Peaker worked at OPPENHEIMER.

Boris Peaker’s has documented 112 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CELC, Celcuity LLC at 15-Aug-2024.

Wall Street Analyst Boris Peaker

Analyst best performing recommendations are on CELC (CELCUITY LLC).
The best stock recommendation documented was for CELC (CELCUITY LLC) at 7/29/2021. The price target of $20.5 was fulfilled within 1 day with a profit of $0.79 (3.71%) receiving and performance score of 37.11.

Average potential price target upside

of $18.52 (20.1%) on MRK (MERCK MPANY).
of $17.9 (157.68%) on HRTX (HERON THERAPEUTI).
of $13.54 (11.02%) on SGEN (SEAGEN).

CLDX Celldex Therapeutics EBS Emergent Biosolutions HRTX Heron Therapeuti SGEN Seagen IRWD Ironwood Pharmaceuticals JNCE Jounce Therapeutics AADI Aadi Bioscience CTMX CytomX Therapeutics NKTR Nektar Therapeutics MRK Merck mpany CTIC CTi Biopharma Corp PCRX Pacira Pharmaceuticals ADCT ADC Therapeutics SA PNT POINT Biopharma Global MGNX MacroGenics CLSD Clearside Biomedical INCY yte MDGL Madrigal Pharmaceuticals MRSN Mersana Therapeutics STML Stemline Therapeutics CELC Celcuity LLC MLTX MoonLake Immunotherapeutics URGN UroGen Pharma Ltd

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Joseph Pantginis (HC WAINWRIGHT)